These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 2565177)
1. Hyperactivity and inattentiveness. School assessment of stimulant treatment. Safer D; Krager JM Clin Pediatr (Phila); 1989 May; 28(5):216-21. PubMed ID: 2565177 [TBL] [Abstract][Full Text] [Related]
2. A survey of medication treatment for hyperactive/inattentive students. Safer DJ; Krager JM JAMA; 1988 Oct; 260(15):2256-8. PubMed ID: 2902237 [TBL] [Abstract][Full Text] [Related]
3. The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools. Safer DJ; Krager JM Pediatrics; 1994 Oct; 94(4 Pt 1):462-4. PubMed ID: 7936853 [TBL] [Abstract][Full Text] [Related]
4. Effect of a media blitz and a threatened lawsuit on stimulant treatment. Safer DJ; Krager JM JAMA; 1992 Aug; 268(8):1004-7. PubMed ID: 1501304 [TBL] [Abstract][Full Text] [Related]
5. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children. Levin H; Hanten G; Max J; Li X; Swank P; Ewing-Cobbs L; Dennis M; Menefee DS; Schachar R J Dev Behav Pediatr; 2007 Apr; 28(2):108-18. PubMed ID: 17435461 [TBL] [Abstract][Full Text] [Related]
6. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. Faraone SV; Glatt SJ J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220 [TBL] [Abstract][Full Text] [Related]
7. Stimulant use and the potential for abuse in Wisconsin as reported by school administrators and longitudinally followed children. Musser CJ; Ahmann PA; Theye FW; Mundt P; Broste SK; Mueller-Rizner N J Dev Behav Pediatr; 1998 Jun; 19(3):187-92. PubMed ID: 9648044 [TBL] [Abstract][Full Text] [Related]
8. The acceptability of interventions for attention-deficit hyperactivity disorder among elementary and middle school teachers. Power TJ; Hess LE; Bennett DS J Dev Behav Pediatr; 1995 Aug; 16(4):238-43. PubMed ID: 7593658 [TBL] [Abstract][Full Text] [Related]
9. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder. Foy JM; Earls MF Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972 [TBL] [Abstract][Full Text] [Related]
10. The nonmedical use of prescription stimulants among dental and dental hygiene students. McNiel AD; Muzzin KB; DeWald JP; McCann AL; Schneiderman ED; Scofield J; Campbell PR J Dent Educ; 2011 Mar; 75(3):365-76. PubMed ID: 21368261 [TBL] [Abstract][Full Text] [Related]
11. Stimulant treatment over five years: adherence, effectiveness, and adverse effects. Charach A; Ickowicz A; Schachar R J Am Acad Child Adolesc Psychiatry; 2004 May; 43(5):559-67. PubMed ID: 15100562 [TBL] [Abstract][Full Text] [Related]
12. Moderators and mediators of long-term adherence to stimulant treatment in children with ADHD. Thiruchelvam D; Charach A; Schachar RJ J Am Acad Child Adolesc Psychiatry; 2001 Aug; 40(8):922-8. PubMed ID: 11501692 [TBL] [Abstract][Full Text] [Related]
13. Stimulant treatment in Maryland public schools. Safer DJ; Malever M Pediatrics; 2000 Sep; 106(3):533-9. PubMed ID: 10969099 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. Rowland AS; Umbach DM; Stallone L; Naftel AJ; Bohlig EM; Sandler DP Am J Public Health; 2002 Feb; 92(2):231-4. PubMed ID: 11818297 [TBL] [Abstract][Full Text] [Related]
15. Attention-Deficit/Hyperactivity Disorder Medication Treatment Impact on Response to Growth Hormone Therapy: Results from the ANSWER Program, a Non-Interventional Study. Rose SR; Reeves G; Gut R; Germak J J Pediatr; 2015 Dec; 167(6):1389-96. PubMed ID: 26394822 [TBL] [Abstract][Full Text] [Related]
16. Update on long-term stimulant medication treatment of attention-deficit hyperactivity disorder. Barbaresi WJ J Dev Behav Pediatr; 2014 Sep; 35(7):446-7. PubMed ID: 25180894 [No Abstract] [Full Text] [Related]
17. Overcoming the barriers to effective treatment for attention-deficit/hyperactivity disorder: a neuro-educational approach. Monastra VJ Int J Psychophysiol; 2005 Oct; 58(1):71-80. PubMed ID: 15927296 [TBL] [Abstract][Full Text] [Related]
18. Long-term stimulant medication treatment of attention-deficit/hyperactivity disorder: results from a population-based study. Barbaresi WJ; Katusic SK; Colligan RC; Weaver AL; Leibson CL; Jacobsen SJ J Dev Behav Pediatr; 2014 Sep; 35(7):448-57. PubMed ID: 25180895 [TBL] [Abstract][Full Text] [Related]
19. Advances and considerations in attention-deficit/hyperactivity disorder pharmacotherapy. Mohammadi M; Akhondzadeh S Acta Med Iran; 2011; 49(8):487-98. PubMed ID: 22009816 [TBL] [Abstract][Full Text] [Related]
20. Inattentive Attention-Deficit/Hyperactivity Disorder, Stimulant Medication, and Weight Loss in a 15-Year-Old Girl: Are We Enabling the Development of an Eating Disorder? Iyer S; Kumar M; Reiff MI; Stein MT J Dev Behav Pediatr; 2015 Sep; 36(7):549-51. PubMed ID: 26348973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]